Total Funding
34
57
Total FundingGrant raised
Growth Score 34 in past quarter
-1 pts
Heat Score 57 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
110487
Biorasis commercializes wireless, needle implantable, miniaturized sensor platforms for real-time glucose monitoring.
- Faquir Jain: Co-Founder & Scientific Advisor
- Fotios Papadimitrakopoulos: Co-Founder & Scientific Advisor
About the Company
BIORASIS was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring.
In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in
the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.
